Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study (Q35650600)
Jump to navigation
Jump to search
scientific article published on February 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study |
scientific article published on February 2004 |
Statements
1 reference
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study (English)
1 reference
Katherine Y Look
1 reference
Alan Sandler
1 reference
John A Blessing
1 reference
Joseph A Lucci
1 reference
Peter G Rose
1 reference
Gynecologic Oncology Group (GOG) Study
1 reference
1 February 2004
1 reference
1 reference
92
1 reference
2
1 reference
644-647
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference